INTRODUCTION {#S6}
============

Atopy is characterised by a tendency to mount immunoglobulin E (IgE)-mediated, type I hypersensitivity reactions to allergens. It is strongly associated with allergic diseases, including asthma. In many Western countries 10-20 percent of the population are affected by atopy and the prevalence of atopic diseases in children and adults has increased in these countries from the 1970s ([@R3]; [@R38]). Although there is evidence of genetic heritability ([@R36]), little is known about modifiable risk factors for atopy that might be used in prevention.

Vitamin D is a key regulator of calcium homeostasis, and biological evidence suggests that vitamin D and calcium might be implicated in atopic diseases and respiratory health, ([@R18]; [@R26]; [@R15]; [@R9]) though epidemiological evidence is limited and inconsistent ([@R10]; [@R23]; [@R14]; [@R12]; [@R22]; [@R20]; [@R19]; [@R33]; [@R29]). Differences in how vitamin D exposure and outcomes were assessed or differences in the confounders that were taken into account in different studies may have contributed to differences between them. Wheezing and associated reduced lung function are amongst the wide range of symptoms associated with atopy and there is some evidence of positive association between vitamin D (measured as serum 25-hydroxyvitamin D \[25(OH)D\] and lung function ([@R10]; [@R33]; [@R7]; [@R5]; [@R35]), although a null association has also been reported ([@R11]).

Previous studies in the US third National Health and Nutrition Examination Survey (NHANES III) have shown positive association between serum calcium and forced expiratory volume in one second (FEV~1)~ ([@R28]) but not with atopy ([@R27]). In addition, higher serum 25(OH)D levels were associated with better lung function in the same study ([@R5]), but it is unknown whether the associations of 25(OH)D were independent of calcium and *vice versa*.

Our study adds to these previous papers by: (i) examining whether the associations of 25(OH)D and calcium are independent of each other: (ii) examining the association of 25(OH)D and calcium with specific allergen sensitisation: (iii) studying the association between serum calcium and FVC and (iv) comparing whether the magnitudes and/or directions of these associations differ between adolescents and adults. The previous lung function studies have included participants older than 17 years only ([@R28]) or older than 20 years ([@R5]). The association between calcium and atopy was studied in 6-16 year olds and 17-59 year olds ([@R27]).

METHODS {#S7}
=======

Sample {#S8}
------

Data from the third US NHANES III were used. NHANES III, conducted between 1988 and 1994, is a survey of the civilian non-institutionalized population of the United States. Data and documentation are available at <http://www.cdc.gov/nchs/nhanes/nh3rrm.htm>. Serum 25(OH)D and calcium measurements were available for participants aged ≥12 years and skin prick allergen responses for participants up to age 59 years (with a random 50 percent of 20-59 year olds having these tests). Thus, we included participants aged 12-59 years, examining adolescents (12-19 years) and adults (20-59 years) separately. [Figure 1](#F1){ref-type="fig"} shows the flow of participants who attended mobile examination clinics and final analyses samples for the studies in adolescents and adults. We only included individuals with complete data on exposures, outcome and all covariables in any analyses meaning that the final sample sizes were 2446 and 2315 adolescents for associations with lung function and allergy tests, respectively and 8049 and 3656 adults for associations with lung function and allergy tests, respectively. The NHANES III study was approved by NHANES Institutional Review Board and documented consent was obtained from participants.

Exposures {#S9}
---------

Serum levels of 25(OH)D and calcium were measured on venous samples. 25(OH)D was assayed with INCSTAR 25-OH-D I^25^ radioimmunoassay (Diasorin, Stillwater, MN, USA) and serum calcium with NOVA 7 analyzer (Nova Biomedical, Waltham, MA, USA). Ionised calcium (adjusted for serum pH) was used in these analyses.

Outcomes {#S10}
--------

Lung function and allergy tests were conducted at mobile examination centres (MECs). Lung function \[FEV~1~ and forced vital capacity (FVC)\] was assessed with a Ohio 827 rolling seal spirometer (Ohio Medical Instrument Company, Cincinnati, OH USA) according to American Thoracic Society criteria (1987) ([@R2]).

The allergen panel consisted of 10 common allergens (*Dermatophagoides farinae*, cat, German cockroach, short ragweed, perennial rye, *Alternaria alternata*, Bermuda grass, Russian thistle, white oak and peanut) and a negative (glycerinated diluent) control. Hypersensitivity reactions were evaluated 15 minutes after administering the allergens on separate sites of examinee\'s forearms with prick-puncture technique. A positive test response was defined as maximum weal diameter≥3mm for allergen and \<3mm for negative control. Atopy was defined as a positive response to one or more allergens. Individuals with severe eczema or signs of skin infection on both arms, those with previous severe response to allergen testing or participants with signs of breathing difficulties were excluded from the allergy tests. We appreciate that these might include individuals with most severe atopy, but due to small numbers (39 adolescents; 111 adults) it was not possible to examine this as an outcome by itself in both adolescents and adults.

Potential confounders {#S11}
---------------------

The following were considered potential confounding factors due to their known or plausible associations with exposures and outcomes: age, gender, race/ethnicity, height, health status, socioeconomic position, outdoor activity and smoking.

Height and weight were measured using standard research procedures at the MECs and were used to calculate body mass index (BMI). Physicians\' impressions of health status (Poor/Fair/Good/Very good/Excellent) at the MECs were used as an indicator of general health. Data on self-reported race/ethnicity, smoking, pets, socioeconomic background, outdoor physical activity and history of respiratory/allergic diseases (emphysema, chronic bronchitis, asthma and hay fever) were obtained during interview. Family poverty-income ratio (below/equal to or above 1) was used as indicator of socioeconomic position. Outdoor activity during past month for adults was derived from the interview data according to method by Scragg and Camargo ([@R32]). These data were not collected from those aged 18 or younger. In adolescents, we adjusted for pubertal stage, which was assessed by Tanner scales ([@R37]). Among adults, smoking status was defined as never, former (has smoked ≥100 cigarettes but not currently smoking), and current smoker. Pack-years of smoking were calculated using answers to 12 tobacco questions and included assessment of current number of cigarettes smoked, maximum number of cigarettes smoked, and periods during which a current smoker did not smoke. Due to the skewed distribution, a categorical variable for pack-years was derived (0, 0.1-4.9, 5-9.9, 10-19.9 and ≥20 pack-years). Because of missing data on pack-years (22% of the adults), in our main analyses we adjusted for smoking status only and in sensitivity analyses we examined the effect of adjusting for pack-years in those with these data. In adolescents, smoking status was classified as current smoker or non-smoker currently due to low frequency of ex-smokers (n=67, 6.3% of those with smoking data available). Because 61.7% of adolescents did not answer the smoking questionnaire, we did not include smoking as a covariable in the main analyses in adolescents but conducted a sensitivity analysis in those with smoking data available to see if adjusting for smoking affected the associations.

Statistical analyses {#S12}
--------------------

Statistical analyses were conducted with Stata 11.0 (Stata Corp LP, College Station, TX USA), using the svy procedure to account for cluster effects and sampling weights from MECs (lung function) and allergy subsamples (allergen sensitisation). A more detailed description of recommended statistical methodology is available in ([@R24]). The associations of 25(OH)D and calcium levels with lung function were analyzed with multivariable linear regression. The association with atopy and sensitisation to allergens were assessed with multivariable logistic regression. Serum calcium, 25(OH)D and spirometry measurements were analyzed as z-scores.

RESULTS {#S13}
=======

The weighted mean (standard error) 25(OH)D and ionised serum calcium levels among adolescents were 80.3 (1.80) nmol/l and 1.25 (0.003) mmol/l. Among adults, the weighted mean 25(OH)D was 75.0 (1.00) nmol/l and weighted mean calcium level was 1.24 (0.003) mmol/l. The correlation coefficient *r* for serum 25(OH)D and ionised calcium was 0.02 (P=0.34) in adolescents and 0.04 (P=0.0009) in adults. There was no statistical evidence that any associations differed between males and females (P for interaction ≥0.13). Therefore, results are presented for males and females combined.

[Supplementary Tables 1-4](#SD1){ref-type="supplementary-material"} summarise the age- and gender-adjusted characteristics of adolescents and adults across quartiles of serum 25(OH)D and ionised calcium. The proportion of females, non-Hispanic blacks and persons from households with poverty/income ratio below 1 decreased across the quartiles of 25(OH)D in adolescents, while the proportion of non-Hispanic whites increased across the quartiles. Adolescents in the higher quartiles had lower Tanner scores. Among adults, mean age and BMI decreased across quartiles of 25(OH)D, and mean serum level of ionised calcium and height increased across the quartiles. The proportion of men, non-Hispanic whites, those reporting outdoor physical activity during past month, and those who had a pet increased across the quartiles of 25(OH)D. The proportion of non-Hispanic blacks, individuals with fair health status and individuals from households with poverty-income ratio below 1 decreased across the quartiles of 25(OH)D in adults.

The proportion of men increased linearly across the quartiles of ionised serum calcium in adults. Mean age and number of pack-years smoked decreased across the calcium quartiles in adults. Among the 12-19 year olds, mean BMI increased across the quartiles. In the adult group, mean serum 25(OH)D increased across the quartiles, while the proportion of Mexican-American and Other ethnicities decreased across the quartiles.

With respect to outcomes, in these age- and gender-adjusted models 25(OH)D was associated positively with FEV~1~ and FVC and inversely with responsiveness to German cockroach allergen in both age groups. In adults, 25(OH)D was inversely associated with the prevalence of atopy, and in adolescents, decreased responsiveness to ragweed, Bermuda grass and perennial rye. Serum ionised calcium was positively associated with sensitisation to short ragweed, Bermuda grass, white oak and peanut allergens in adults only. Ionised calcium was not associated with any outcomes in adolescents, or with other outcomes in adults. Where associations occurred they appeared linear across the quartiles.

Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} show multivariable associations of 25(OH)D and calcium with lung function in adolescents and adults respectively. In adolescents ([Table 1](#T1){ref-type="table"}), 25(OH)D was positively associated with FVC in the confounder adjusted model, but not with FEV~1~. Additional adjustment for pubertal stage (n=1566) did not alter the associations presented (results available from authors). In adults ([Table 2](#T2){ref-type="table"}) serum 25(OH)D levels were positively associated with both FEV~1~ and FVC after adjusting for all potential confounders (Model 2). Ionised serum calcium was not associated lung function in adolescents or adults (Tables [1](#T1){ref-type="table"}-[2](#T2){ref-type="table"}). With additional mutual adjustment (associations of 25(OH)D adjusted for ionised calcium and *vice versa*) the associations remained unchanged (Model 3 in Tables [1](#T1){ref-type="table"}-[2](#T2){ref-type="table"}).

Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"} summarise the multivariable associations of 25(OH)D and calcium levels with previously diagnosed respiratory or allergic diseases and atopic outcomes in adolescents and adults. No associations were observed in adolescents ([Table 3](#T3){ref-type="table"}) and serum 25(OH)D levels were not associated with allergic diseases or allergen sensitisation in adults, apart from slightly decreased sensitisation to German cockroach allergen ([Table4](#T4){ref-type="table"}), Higher calcium levels were associated with increased sensitisation to short ragweed, Bermuda grass, white oak and peanut allergens, when adjusted for age, gender, race/ethnicity and height (model 1). With adjustment for additional confounders (Model 2) and 25(OH)D (Model3) the associations with sensitisation to short ragweed and Bermuda grass allergen remained, but other associations were attenuated to the null.

Sensitivity analyses are shown in [supplementary Tables 5-12](#SD1){ref-type="supplementary-material"}. In the subgroups of adolescents with smoking data and adults with data on pack-years associations that were the equivalent of Models 1-3 for the whole eligible sample (Tables [1](#T1){ref-type="table"}-[4](#T4){ref-type="table"}) were markedly different in inconsistent ways, suggesting that analyses in these subgroups may be affected by selection bias. Adjusting for smoking in adolescents and pack-years in adults did not markedly alter associations in these subgroups.

DISCUSSION {#S14}
==========

We showed that the previously reported positive association of 25(OH)D with FVC and FEV~1~ in adults ([@R5]) is independent of serum calcium levels, and not due decreased risk of allergen sensitisation or respiratory diseases, as serum 25(OH)D levels were not associated with these outcomes. In addition, the association between 25(OH)D levels and FVC, but not with FEV~1~ was observed in adolescents, whereas a previous publication using NHANES III data had only explored this association in adults ([@R5]). As with adults, this association was independent of calcium and allergen sensitisation. We did not find an association between ionised serum calcium and lung function in either adolescents or adults, although a previous study reported a positive association between ionised calcium and FEV~1~ among NHANES III participants age≥17 years ([@R28]). That previous study did not address the association between FVC and calcium. The difference between our results and those of that previous NHANES study are likely to be due to differences in age ranges and numbers of participants included in the analyses of the two papers. We were interested in exploring whether associations differed between adolescents (defined as those aged 12-19) and adults, who had data on allergen sensitisation (20-59 year old). By contrast McKeever *et al*. were exploring associations in adults only (defined as anyone aged 17 years or older), consequently they had larger numbers. McKeever et al. also categorised calcium in a different way to the way we have used this variable. When we repeat our analyses using calcium in the same way as that used by McKeever et al. we still find no strong statistical evidence of an association in either of the age groups we examined, by contrast we can perfectly replicate McKeevers results in those aged 17 years and above.

Vitamin D and lung function {#S15}
---------------------------

Several mechanisms may link higher vitamin D levels to better lung function. The positive association of 25(OH)D with lung function might be the result of vitamin D protecting against atopic asthma, but we found no evidence that higher levels of 25(OH)D were associated with decreased allergic responsiveness to common allergens. FEV~1~ is primarily used as a measure of intrathoracic airway obstruction, as seen in asthma, in clinical and epidemiological settings, although changes in total lung capacity (TLC) will affect both FEV~1~ and FVC. FVC is a dynamic representation of the difference between TLC and residual volume and, in healthy subjects, it is likely to vary with TLC and reflect lung growth. It is therefore possible that the positive association of 25(OH)D with FVC in adolescents reflects the established role of vitamin D in skeletal growth ([@R17]), i.e. higher 25(OH)D is related to greater height via beneficial effects on skeletal development and greater height is associated with greater lung volume. However, all associations were adjusted for height and so this is unlikely to fully explain the association. In adults 25(OH)D was positively associated with both FEV~1~ and FVC, supporting a role beyond the relation to skeletal development.

High consumption of antioxidants have been associated with lung function,(e.g ([@R13])) so it is possible that the association of vitamin D is mediated via its antioxidative properties. Alternative mechanisms might be the regulation of immune response, cellular differentiation and/or proliferation by vitamin D ([@R4]; [@R39]). Vitamin D receptor is present in human bronchial smooth muscle cells, epithelial cells lining the respiratory tract, activated lymphocytes and antigen-presenting cells([@R39]; [@R6]), which support the local functions of vitamin D in the lungs and in the immune system. Therefore, it could be that vitamin D regulates the growth of bronchial smooth muscle cells or protects from the lung inflammation by promoting the expression of antimicrobial peptides and through anti-inflammatory mechanisms ([@R4]; [@R39]). Alterations in calcium homeostasis are known to occur in asthma sufferers ([@R9]), so it would be tempting to speculate this as a possible mechanism, although in our study circulating levels of ionised calcium were not associated with lung function, However, despite the lack of association between serum calcium levels and lung function, local calcaemic effects such as alterations in intracellular calcium signalling could still relate to the mechanism.

Ionised calcium and atopy {#S16}
-------------------------

Our results suggest that variation in ionised serum calcium is more robustly associated with allergic response to common allergens in adults than is variation in vitamin D. In adults positive associations were found with sensitisation to grass allergens and peanut, although apart from short ragweed and Bermuda grass, these associations were attenuated towards the null after adjusting for confounders. Experimental studies suggest that calcium is involved in allergic response: bronchial smooth muscle contraction, mast cells granulation and histamine release from mast cells are calcium-dependent ([@R15]; [@R1]) and effects of vitamin D on the immune system depend on adequate calcium levels ([@R8]). Both intra- and extracellular calcium levels have been shown to regulate the histamine release ([@R1]), so one would perhaps expect to see a disruption of calcium homeostasis in atopy, although intracellular calcium levels are strictly controlled and thus unlikely to be affected by normal variation in serum calcium levels. In addition, the calcium-binding motifs in allergens, especially of grass origin, are necessary for IgE binding and the chelation of calcium ions from sera of allergic patients lead to decreased allergen-IgE binding or prevented this occurring ([@R34]; [@R25]). To our knowledge only one previous study has examined the association of circulating calcium with allergic response and that cross-sectional study found no association ([@R27]). The positive associations we have found here in adults require further exploration.

Study strengths and limitations {#S17}
-------------------------------

The main strengths of this study are its sample size, examination of associations with serum measurements of 25(OH)D and calcium rather than dietary reports, examination with objectively assessed outcomes of lung function and allergic response to common allergens, comparison of associations in adolescents and adults and the ability to adjust for a wide range of potential confounding factors. In adults we were only able to adjust for smoking status (current/ex/never) for our main analyses and, whilst sensitivity analyses suggested that adjustment for pack-years in the subgroup with these data did not result in greater attenuation compared with smoking status, there was some evidence that selection bias may have influenced this subgroup analysis. Similarly, in adolescents we were unable to adjust for smoking in the main analysis and those with smoking data appeared to be a selected subgroup.

Because this study is cross-sectional, we cannot rule out reverse causality as an explanation for the observed associations. Further exploration in prospective studies are warranted, though we are unaware of any studies that currently have measurements of serum 25(OH)D and calcium with later objectively measured lung function and response to common allergens. NHANES III has single measurements of calcium and 25(OH)D, which may be inadequate to reflect long-term status ([@R31]), although a single measurement may be a useful biomarker of season-specific vitamin D status over a longer time ([@R16]) and serum calcium levels are normally maintained at relatively narrow limits within individuals ([@R30]). Other studies, including those finding associations with bone phenotypes ([@R21]), have used single measurements of 25(OH)D. A further limitation is the lack of data on IgE and parathyroid hormone levels.

Conclusions {#S18}
-----------

Our findings contribute to the emerging literature on a possible role of vitamin D and calcium with lung function and atopy. We showed that the positive cross-sectional association between serum 25(OH)D levels and lung function is independent of variation in ionised calcium levels and does not appear to be driven by increased allergen sensitisation. By contrast we report a novel positive association between serum levels of ionised calcium and grass allergen sensitisation in adults, which is independent of a wide-range of potential confounding factors and of vitamin D.
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###### 

Association of circulating 25(OH)D and ionised calcium (n2446) with lung function in 12-19 year olds.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
           Mean difference in respiratory function (SD) per 1 SD change\   Mean difference in respiratory function (SD) per 1 SD\                                                                                   
           in 25(OH)D (95%CI)                                              change in ionised serum calcium (95%CI)                                                                                                  
  -------- --------------------------------------------------------------- -------------------------------------------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  FEV~1~   753                                                             0.009\                                                   0.009\              0.008\              0.010\              0.010\              0.010\
                                                                           (−0.028 to 0.046)                                        (−0.028 to 0.046)   (−0.028 to 0.045)   (−0.024 to 0.045)   (−0.024 to 0.045)   (−0.024 to 0.044)

  FVC      901                                                             0.036\                                                   0.036\              0.035\              0.007\              0.007\              0.005\
                                                                           (0.007 to 0.065)                                         (0.007 to 0.065)    (0.007 to 0.064)    (−0.024 to 0.038)   (−0.024 to 0.038)   (−0.025 to 0.034)
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FEV~1~ forced expiratory volume in 1 second; FVC forced vital capacity

Model 1 is adjusted for age, ethnicity/race, gender and height

Model 2 as Model 1, plus additional adjustment for BMI, poverty index, household pets (cat/dog/bird), general health and diagnosed asthma/hay fever/chronic bronchitis

Model 3 as Model 2, plus additional adjustment for calcium in 25(OH)D analysis and 25(OH)D in calcium analysis

###### 

Association of circulating 25(OH)D and ionised calcium(n=8049) with lung function in 20-59 year olds.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
           Mean difference in respiratory function(SD) per 1 SD change in\   Mean difference in respiratory function(SD) per 1 SD\                                                                                 
           25(OH)D(95%CI)                                                    change in ionised serum calcium(95%CI)                                                                                                
  -------- ----------------------------------------------------------------- ------------------------------------------------------- ------------------ ------------------ ------------------- ------------------- -------------------
  FEV~1~   821                                                               0.034\                                                  0.023\             0.023\             0.006\              0.002\              0.000\
                                                                             (0.016 to 0.052)                                        (0.004 to 0.041)   (0.005 to 0.041)   (−0.012 to 0.025)   (−0.018 to 0.021)   (−0.019 to 0.019)

  FVC      1006                                                              0.043\                                                  0.032\             0.032\             0.004\              −0.001\             −0.003\
                                                                             (0.024 to 0.061)                                        (0.015 to 0.049)   (0.015 to 0.049)   (−0.018 to 0.025)   (−0.022 to 0.020)   (−0.024 to 0.018)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

FEV~1~ forced expiratory volume in 1 second; FVC forced vital capacity

Model 1 is adjusted for age, ethnicity/race, gender and height

Model 2 as Model 1, plus additional adjustment for BMI, poverty index, household pets(cat/dog/bird), general health, outdoor activity during last month, smoking and diagnosed asthma/emphysema/hay fever/chronic bronchitis

Model 3 as Model 2, plus additional adjustment for calcium in 25(OH)D analysis and 25(OH)D in calcium analysis

###### 

Association of circulating 25(OH)D and ionised calcium levels with previously diagnosed respiratory/allergic diseases (asthma, chronic bronchitis or hay fever) (n=2446) and allergy test results (n=2317) in 12-19 year olds

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                     Odds ratio for each allergen outcome per 1SD change in 25(OH)D (95%CI)   Odds ratio for each allergen outcome per 1SD change in ionised serum calcium (95%CI)                                                                               
  ------------------ ------------------------------------------------------------------------ -------------------------------------------------------------------------------------- ------------------ ------------------ ------------------ ------------------ ------------------
  Respiratory\       16.3                                                                     0.92 (0.76-1.13)                                                                       0.92 (0.76-1.13)   0.92 (0.75-1.12)   1.09 (0.91-1.29)   1.09 (0.91-1.29)   1.09 (0.92-1.30)
  disease                                                                                                                                                                                                                                                        

  Atopy              60.6                                                                     1.05 (0.89-1.24)                                                                       1.06 (0.90-1.26)   1.06 (0.90-1.26)   1.03 (0.89-1.19)   1.01 (0.88-1.17)   1.01 (0.87-1.16)

  *D.farinae*        31.1                                                                     0.96 (0.79-1.18)                                                                       0.97 (0.80-1.17)   0.97 (0.80-1.18)   0.98 (0.83-1.15)   0.96 (0.81-1.14)   0.96 (0.81-1.14)

  Cat                18.4                                                                     0.93 (0.78-1.10)                                                                       0.93 (0.78-1.11)   0.94 (0.78-1.12)   0.94 (0.76-1.18)   0.93 (0.73-1.18)   0.93 (0.73-1.18)

  German cockroach   32.9                                                                     0.90 (0.77-1.05)                                                                       0.92 (0.79-1.08)   0.92 (0.79-1.08)   1.03 (0.85-1.26)   1.03 (0.83-1.27)   1.03 (0.84-1.27)

  Short ragweed      31.6                                                                     0.92 (0.79-1.06)                                                                       0.94 (0.81-1.08)   0.93 (0.81-1.08)   1.06 (0.91-1.23)   1.04 (0.90-1.22)   1.05 (0.90-1.22)

  Bermuda grass      23.1                                                                     0.95 (0.80-1.14)                                                                       0.96 (0.79-1.16)   0.96 (0.79-1.16)   0.98 (0.80-1.21)   0.97 (0.79-1.20)   0.98 (0.79-1.20)

  Perennial rye      31.6                                                                     0.96 (0.81-1.14)                                                                       0.96 (0.81-1.14)   0.96 (0.82-1.14)   1.00 (0.87-1.14)   0.99 (0.86-1.14)   0.99 (0.86-1.14)

  Russian thistle    18.6                                                                     1.06 (0.90-1.25)                                                                       1.08 (0.91-1.29)   1.08 (0.91-1.30)   0.95 (0.78-1.16)   0.94 (0.76-1.17)   0.94 (0.75-1.18)

  White oak          13.5                                                                     0.99 (0.83-1.18)                                                                       1.01 (0.83-1.24)   1.01 (0.83-1.24)   1.03 (0.80-1.33)   1.02 (0.76-1.38)   1.02 (0.76-1.38)

  *A. alternata*     18.2                                                                     1.06 (0.89-1.26)                                                                       1.09 (0.90-1.32)   1.09 (0.90-1.32)   1.08 (0.86-1.35)   1.07 (0.83-1.38)   1.06 (0.82-1.38)

  Peanut             10.6                                                                     0.92 (0.74-1.15)                                                                       0.93 (0.74-1.17)   0.93 (0.74-1.17)   0.99 (0.82-1.21)   0.98 (0.81-1.18)   0.98 (0.81-1.19)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Prev: Prevalence

Model 1 is adjusted for age, ethnicity/race, gender and height

Model 2 as Model 1, plus additional adjustment for BMI, poverty index, household pets (cat/dog/bird), general health and (for other outcomes than respiratory disease) diagnosed asthma/hay fever/chronic bronchitis

Model 3 as Model 2, plus additional adjustment for calcium in 25(OH)D analysis and 25(OH)D in calcium analysis

###### 

Association of circulating 25(OH)D and ionised calcium levels with previously diagnosed respiratory/allergic diseases(asthma, chronic bronchitis or hay fever, n=8049) and allergy test results (n=3656) in 20-59 year olds

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                     Odds ratio for each allergen outcome per 1SD change in 25(OH)D (95%CI)   Odds ratio for each allergen outcome per 1SD change in ionised serum calcium (95%CI)                                                                               
  ------------------ ------------------------------------------------------------------------ -------------------------------------------------------------------------------------- ------------------ ------------------ ------------------ ------------------ ------------------
  Respiratory\       16.1                                                                     0.96 (0.85-1.09)                                                                       0.96 (0.85-1.09)   0.96 (0.84-1.09)   1.04 (0.95-1.15)   1.04 (0.94-1.15)   1.04 (0.94-1.16)
  disease                                                                                                                                                                                                                                                        

  Atopy              57.8                                                                     0.97 (0.85-1.11)                                                                       0.98 (0.86-1.12)   0.98 (0.85-1.12)   1.06 (0.97-1.15)   1.03 (0.95-1.13)   1.03 (0.95-1.13)

  *D.farinae*        29.0                                                                     1.01 (0.88-1.16)                                                                       1.02 (0.89-1.18)   1.02 (0.89-1.17)   1.04 (0.93-1.17)   1.03 (0.91-1.16)   1.03 (0.92-1.15)

  Cat                18.1                                                                     1.07 (0.91-1.27)                                                                       1.08 (0.91-1.27)   1.07 (0.91-1.27)   1.09 (0.98-1.22)   1.04 (0.92-1.16)   1.03 (0.92-1.16)

  German cockroach   32.3                                                                     0.89 (0.79-1.01)                                                                       0.89 (0.79-1.01)   0.89 (0.78-1.01)   1.05 (0.95-1.15)   1.04 (0.94-1.15)   1.05 (0.95-1.16)

  Short ragweed      29.2                                                                     1.04 (0.91-1.19)                                                                       1.05 (0.92-1.21)   1.05 (0.91-1.20)   1.15 (1.01-1.31)   1.14 (1.01-1.29)   1.15 (1.02-1.30)

  Bermuda grass      20.8                                                                     0.96 (0.83-1.10)                                                                       0.95 (0.82-1.10)   0.94 (0.81-1.09)   1.18 (1.06-1.32)   1.14 (1.01-1.29)   1.15 (1.02-1.30)

  Perennial rye      28.5                                                                     0.98 (0.87-1.12)                                                                       0.97 (0.85-1.12)   0.97 (0.85-1.12)   1.06 (0.97-1.16)   1.02 (0.94-1.12)   1.03 (0.94-1.12)

  Russian thistle    17.7                                                                     0.92 (0.80-1.07)                                                                       0.91 (0.78-1.06)   0.91 (0.78-1.06)   1.10 (0.96-1.27)   1.06 (0.91-1.24)   1.07 (0.91-1.24)

  White oak          13.5                                                                     1.03 (0.88-1.21)                                                                       1.02 (0.87-1.20)   1.02 (0.87-1.19)   1.17 (1.03-1.32)   1.11 (0.98-1.26)   1.11 (0.98-1.26)

  *A. alternata*     13.5                                                                     1.04 (0.90-1.21)                                                                       1.03 (0.87-1.21)   1.03 (0.88-1.22)   0.99 (0.86-1.15)   0.94 (0.81-1.08)   0.93 (0.81-1.08)

  Peanut             9.8                                                                      1.01 (0.86-1.18)                                                                       1.00 (0.86-1.16)   0.99 (0.85-1.16)   1.19 (1.02-1.39)   1.15 (0.98-1.34)   1.15 (0.98-1.34)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Prev: Prevalence

Model 1 is adjusted for age, ethnicity/race, gender and height

Model 2 as Model 1 plus additional adjustment for BMI, poverty index, household pets (cat/dog/bird), general health, outdoor activity during last month, smoking and (for other outcomes than respiratory disease) diagnosed asthma/emphysema/hay fever/chronic bronchitis

Model 3 as Model 2, plus additional adjustment for calcium in 25(OH)D analysis and 25(OH)D in calcium analysis
